Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA09 Bendamustine
D07085 Bendamustine hydrochloride (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Bendamustine
D07085 Bendamustine hydrochloride (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D07085 Bendamustine hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01678 Nitrogen mustard analog
DG00678 Bendamustine
D07085 Bendamustine hydrochloride
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D07085
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D07085
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D07085
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01678 Nitrogen mustard analog
DG00678 Bendamustine